本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

22.10
+0.85504.03%
成交量:37.66萬
成交額:820.06萬
市值:25.03億
市盈率:-6.39
高:22.18
開:21.47
低:21.27
收:21.24
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:0.86
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.44
市盈率(LYR):-6.65

資料載入中...

2022/05/12

重要事件披露

8-K - Current report
2022/04/05

重要事件披露

8-K - Current report
2022/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/15

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/08

重要事件披露

8-K - Current report
2021/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]